{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:38:49Z","timestamp":1792100329180,"version":"4.4.0"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1001\/jamaneurol.2019.3446","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T17:34:25Z","timestamp":1571074465000},"page":"192","source":"Crossref","is-referenced-by-count":83,"title":["Risk of Developing Parkinson Disease in Bipolar Disorder"],"prefix":"10.1001","volume":"77","author":[{"given":"Patr\u00edcia R.","family":"Faustino","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo S.","family":"Duarte","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Chendo","sequence":"additional","affiliation":[{"name":"Psychiatry Department, Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal"},{"name":"Cl\u00ednica Universit\u00e1ria de Psiquiatria, Faculty of Medicine, University of Lisbon, Lisbon, Portugal"},{"name":"CNS\u2014Campus Neurol\u00f3gico Senior, Torres Vedras, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Castro Caldas","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"},{"name":"CNS\u2014Campus Neurol\u00f3gico Senior, Torres Vedras, Portugal"},{"name":"Neurology Service, Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Reim\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"},{"name":"Neurological Imaging Department, Hospital de Santa Maria, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo M.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Vale","sequence":"additional","affiliation":[{"name":"Neurological Imaging Department, Hospital de Santa Maria, Lisbon, Portugal"},{"name":"Neurology Department, Hospital de Beatriz Angelo, Loures, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tinazzi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Biomedicine and Movement Sciences, Universit\u00e0 di Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Institute of Neurology, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, Portugal"},{"name":"CNS\u2014Campus Neurol\u00f3gico Senior, Torres Vedras, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi190086r1","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders.","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"5280","key":"noi190086r2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/229135a0","article-title":"Regular induction of hypomania by L-dopa in \u201cbipolar\u201d manic-depressive patients.","volume":"229","author":"Murphy","year":"1971","journal-title":"Nature"},{"issue":"2","key":"noi190086r3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1176\/ps.50.2.201","article-title":"A review of bipolar disorder among adults.","volume":"50","author":"Hilty","year":"1999","journal-title":"Psychiatr Serv"},{"issue":"434","key":"noi190086r4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/acp.2007.116.issue-s434","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.","volume":"116","author":"Berk","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"1","key":"noi190086r5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism.","volume":"8","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"issue":"12","key":"noi190086r6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1002\/mds.v31.12","article-title":"Hospital care for mental health and substance abuse conditions in Parkinson\u2019s disease.","volume":"31","author":"Willis","year":"2016","journal-title":"Mov Disord"},{"issue":"6","key":"noi190086r7","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease.","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"issue":"3","key":"noi190086r10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.annepidem.2013.12.010","article-title":"Psychiatric diseases predated the occurrence of Parkinson disease: a retrospective cohort study.","volume":"24","author":"Lin","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"4","key":"noi190086r11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jagp.2015.11.004","article-title":"Lithium use in older adults is associated with increased prescribing of Parkinson medications.","volume":"24","author":"Marras","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"noi190086r12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/acp.2001.104.issue-5","article-title":"Increased risk of developing Parkinson\u2019s disease for patients with major affective disorder: a register study.","volume":"104","author":"Nilsson","year":"2001","journal-title":"Acta Psychiatr Scand"},{"issue":"24","key":"noi190086r13","doi-asserted-by":"publisher","first-page":"e2735","DOI":"10.1212\/WNL.0000000000007649","article-title":"Bipolar disorder and risk of Parkinson disease: a nationwide longitudinal study.","volume":"92","author":"Huang","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"noi190086r14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1192\/bjp.bp.114.152249","article-title":"Comorbid medical illness in bipolar disorder.","volume":"205","author":"Forty","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"5","key":"noi190086r15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/bdi.2004.6.issue-5","article-title":"Burden of general medical conditions among individuals with bipolar disorder.","volume":"6","author":"Kilbourne","year":"2004","journal-title":"Bipolar Disord"},{"key":"noi190086r16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/1741-7015-11-263","article-title":"Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study.","volume":"11","author":"Smith","year":"2013","journal-title":"BMC Med"},{"key":"noi190086r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","article-title":"Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses.","volume":"23","author":"Bellou","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"noi190086r18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0033291700000702","article-title":"Mood swings associated with the \u2018on-off\u2019 phenomenon in Parkinson\u2019s disease.","volume":"17","author":"Nissenbaum","year":"1987","journal-title":"Psychol Med"},{"key":"noi190086r9","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0","author":"Sterne","year":"2017"},{"key":"noi190086r8","unstructured":"WellsGA, SheaB, O\u2019ConnellD, . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed February 10, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2752486\/jamaneurology_faustino_2019_oi_190086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T16:02:13Z","timestamp":1581350533000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2752486"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.3446","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}